Testing effectiveness (Phase 2)Ended earlyNCT03566511
What this trial is testing
Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide
Who this might be right for
Diabetes Mellitus, Type 2Glucose, High BloodGlucose Metabolism Disorders (Including Diabetes Mellitus)
Meredith Hawkins 37